Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Cytochroma begins first of two identical phase III studies of CTAP-101

Sep. 21, 2012

Nymox provides update on phase III BPH study

Sep. 19, 2012

Takeda obtains U.K. license for erectile dysfunction medication

Sep. 14, 2012

Santaris Pharma discloses new oligonucleotides

Sep. 12, 2012

Targacept to develop TC-5214 in overactive bladder

Sep. 6, 2012

New tamsulosin prodrugs prepared by Synthon

Sep. 6, 2012

AlloCure begins phase II study in acute kidney injury

Sep. 5, 2012

Adenosine-based therapy shows promise for the treatment of priapism

Sep. 4, 2012

Phase I/II data suggest transrectal administration of PRX-302 is well tolerated in BPH

Sep. 3, 2012

New data presented on Xiaflex in Peyronie's disease

Aug. 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.